Xavier Leroux


Xavier Leroux


Paris | 32 rue de Monceau, Paris, France 75008
+33 1 57 57 80 13 | +33 1 57 57 80 81


Xavier Leroux focuses his practice on private equity and M&A transactions for public and private companies, with experience in both French and international matters. He has extensive experience representing companies and managers on the one hand, and investment funds on the other hand, in private equity transactions, including leveraged buyouts, growth capital, private placement, and assistance at all stages of a company's investment life cycle.

Mr. Leroux has been involved in several domestic and cross-border acquisitions, divestitures, and internal reorganizations.

Before joining Dechert, Mr. Leroux interned in the corporate and securities department of another international law firm.


Private Equity / M&A

  • A French private equity firm on its investment in a leading tour operator and travel agent in France (Certares 2018)
  • An infrared specialist on its exclusive negotiations with a US fund (HGH Infrared Systems 2018)
  • A French public venture capital fund on its investments into French startups (Linkfluence, Bnbsitter, Comitéo, MOPeasy, Navya 2015 / 2016)
  • A major US manufacturer of household products on the sale of its in vitro diagnostic distribution business to a French listed company (Fumouze 2016)
  • A French big data startup on its $10 million fundraising from French and US venture capital funds (Shift Technology 2016)
  • A Sino-French venture capital fund on its acquisition of a French Contract Manufacturing Organization (LBO Cenexi 2015)
  • A French venture capital fund on the sale of one of its portfolio company to a French leading care facility player (Idéal Résidences 2015)
  • A French medtech on its €6 million venture loan (SpineGuard 2015)
  • A US growth capital fund in connection with several prefered rounds of a French unicorn (BlaBlaCar 2014)
  • A French venture capital fund on its acquisition of a French leading care facility player (LBO Colisée 2014)

IPO / Public M&A

  • An innovative biotechnology company on the success of its IPO in compartment C of the Euronext regulated market in Paris, raising €32 million (Poxel IPO 2015)
  • A French medtech company on the success of its IPO on Alternext in Paris, raising €8 million (SpineGuard IPO  2013)
  • Université Paris 2 Panthéon-Assas, Master 1, 2007
  • Université de Cergy-Pontoise, DJCE, 2008
  • Vermont Law School, LL.M., 2009
  • New York
  • Paris
  • French
  • English